Upcoming Events

Request for
event support

If you wish to ask for a funding support from us for an event, please fill out the application form underneath and send it to:

6th of April 2022, Zurich


Keynote by Prof. Andreas Keller, PhD, Chair for Clinical Bioinformatics at Saarland University
We are very excited to welcome Prof. Andreas Keller as our final keynote speaker for the conference! At the merger of Life Sciences and Computer Sciences Andreas is using integrated multiscaling models and network analysis combining all sorts of methodology and modality to better understand human health and disease. He is going to speak about “Understanding gene expression in aeging and neurodegeneration at single cell resolution”.

Simon Häfliger, MD-PhD, at Parallel Session of the Comprehensive Cancer Center Zurich
The C3Z has invited Simon Häfliger, MD-PhD, as a speaker to their parallel session on Wednesday afternoon. Simon’s focus areas are gastrointestinal tumors, head & neck tumors and melanoma.

Don’t forget to submit your abstracts for contributed talks or posters until this Friday April 8th!

Profit from our early-bird registration fees and register before April 15th!
A detailed agenda is available on our website.

We look forward to seeing you in June!

On behalf of the organizing committee,
Sara Gerber, Daniel Stekhoven & Christian Stirnimann

14th of April 2022, Zurich


Dear colleagues from the SPHN community, 


We invite you to join us for the next edition of the SPHN Webinar series, featuring a talk from the following PHRT-funded Project: 


Prof. Roger Schibli

Center for Radiopharmaceutical Sciences, ETHZ-PSI-USZ

A Translational Platform for New Theragnostics

Registrationclick here

Date: 27th April 2022

Time: 11:00-12:00

About this Webinar:

Functional imaging of biological and pathological processes at a molecular level using positron emission tomography (PET) offers an unparalleled opportunity for personalized medicine in the future. With this Technology Transfer Project (TTP) we improve the availability of radionuclides and radiotracers for clinical studies we have established and improved the radiopharmacy platform to facilitate the production of innovative radiotracers according to Good Manufacturing Practice (GMP) for clinical studies. As part of the improvement, we installed automated radiosyntheses modules at the Paul Scherrer Institute as well a solid target station at the 18 MeV medical cyclotron of the ETH Hönggerberg.


Till today the TTP has produced the radiotracers: i) [18F]-AV1451 (to detect Tau-pathy in Alzheimer's patient) for ongoing clinical studies at the USZ, HUG and CHUV; ii) [18F]-AzaFol (targeting the folate receptor on tumor cells) for a multi-center, first-in-man study at the USZ, CHUV and the Cantonal Hospital St. Gallen; iii) [18F]-PSS-232 (targeting the mGluR5) for a clinical study investigating glutamate release after N-acetylcystein challenge and; iv) [177Lu]-PP-F11N a optimized minigastrin analog against the cholecystokinin receptor 2 expressed on medullary thyroid cancer. Overall more than half a dozen clinical studies were enabled and facilitated with the support since the start of the TTP within the PHRT initiative. We will present selected examples of the translational research activities from-bench-to bedside.


Visit our website to watch previous SPHN Webinars and pre-register for the next ones at

If you have any questions, please write to

We very much look forward to your participation! 

19 July 2022, Basel


Symposium in honor of P.J. Meier-Abt


The aim is to discuss how scientists, clinicians, regulators, research
ethics committees, academic institutions, and funding agencies
share responsibilities to enhance value and progress in science and
medicine. This was a key concern of Prof. Meier-Abt as a researcher
and former vice-rector of the University of Basel.
National and international speakers from renowned universities will
present cutting-edge examples of data sharing and collaboration
between various actors that are vital to foster high quality international
biomedical research. Concrete steps will be debated regarding
how to overcome present shortcomings, enhance translation in
biomedicine, and strive towards a culture of collaboration.


Participation in the symposium is free but subject to prior registration at: